Company intelligence
Amass
A Scientific Intelligence Platform for Life Sciences - https://www.amass.tech
About Amass
Amass is a scientific intelligence platform for R&D and business development teams in biotech and pharma. We help teams evaluate scientific claims, map competitive landscapes, and make better decisions across pipelines and external opportunities. The platform analyzes publications, patents, clinical trials, regulatory data, and internal sources such as ELNs and company datasets to generate structured, evidence-based insights. Common use cases include: • Scientific due diligence • Pipeline and target evaluation • Competitive intelligence • Literature review and evidence synthesis Used by teams across pharma, biotech, and life science investors. Available as SaaS, API, and enterprise integrations into internal R&D workflows.
Verified activity
Signals from Amass
4 published signals
Products & Services
Amass launched its new app update for AI and scientific research, featuring a rebuilt end-to-end app with eight connected scientific databases.
Reported by Amass
Products & Services
Amass is launching v2 of its app, fundamentally rebuilt on top of its Core infrastructure of interconnected, semantically enriched life science datasets.
Reported by Alexander Junge
Products & Services
Amass released a new version of the Amass app featuring a new Core architecture and integration with Anthropic.
Reported by Henrik Jensen
Presence & Recognition
Amass is joining forces with Nebius age.house and Tavily ElevenLabs to support longevity scientist Karolinska Institutet and Linköping University Linus Petersson in his quest to prolong life.
Reported by Henrik Jensen